Cryoablation for the treatment of renal cell carcinoma
Kidney Cancer is one of the most common types of cancer and usually affects adults in their 60s/70s.
More than 90% of kidney cancer diagnoses are renal cell carcinoma (RCC).
Mortality incidence of kidney cancer1
Due to the increasing incidence of renal cell carcinoma in recent years, particular attention has been directed towards cryoablation as cancer’s treatment.
Want to learn more about the clinical data available on cryoablation vs partial nephrectomy?
Discover the latest clinical data on cryoablation for RCC
Large studies show comparable oncological outcomes to surgery, with fewer complications and a shorter hospital stay. 
Recently, cryoablation has been increasingly recognised by urologists, oncologists, and interventional radiologists as a preferred treatment for RCC. Indeed, percutaneous cryoablation is now endorsed by the European Association of Urology (EAU) as a highly effective technique in terms of success rates (> 95%)3, particularly in patients with stage 1a or 1b RCC3, 4, 5.